← Leaderboards
Kevin Michael Haigis
Massachusetts Institute Of Technology
$17,260,553
Attributed
$23,727,616
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2006–24$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$23,727,616 · 10
By mechanism
R01$14,561,760 · 7
U01$8,385,083 · 2
K01$780,773 · 1
Top collaborators
- Douglas A Lauffenburger9 shared
- Stephen J Elledge6 shared
- Robert J Coffey5 shared
- Wilhelm Haas5 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Melissa Lambeth Kemp$6,544,663
- Peter Karl Sorger$53,861,857
- Linda G. Griffith$21,069,415
- Wilhelm Haas$3,090,908
- Douglas Scott Jones$158,382
Others in their field
Top investigators on “Mutant”
- Kc Kent Lloyd · University Of California At Davis$103,993,616
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Bruce A Beutler · Ut Southwestern Medical Center$34,438,453
- Oscar A. Carretero · Henry Ford Health System$33,594,856
- Stuart H Orkin · Children'S Hospital Boston$33,454,343
- Tracy T Batchelor · Dana-Farber Cancer Inst$31,851,614
Research focus
MutantGeneticSignal TransductionMolecularGenetically Engineered MousePathway InteractionsBaseResponseMalignant NeoplasmsColorectal CancerMutationSignal PathwayAffectCellsMouse ModelGenesResistanceKras2 GeneIn VivoOncogenicPropertyNovel TherapeuticsCessation Of LifeAmerican
Grant awards (50)
Mouse models of Kras-mutant colorectal cancer$595,434
R01 · FY2024 · CA · contact PI
Mouse models of Kras-mutant colorectal cancer$626,771
R01 · FY2023 · CA · contact PI
Tissue-specific genetic interactions in cancer$862,273
R01 · FY2022 · CA · contact PI
Mouse models of Kras-mutant colorectal cancer$614,235
R01 · FY2022 · CA · contact PI
Systems approaches to understanding the relationships between genotype, signaling, and therapeutic efficacy$679,295
U01 · FY2021 · CA
Mouse models of Kras-mutant colorectal cancer$626,771
R01 · FY2021 · CA · contact PI
Tissue-specific genetic interactions in cancer$512,745
R01 · FY2021 · CA · contact PI
Systems approaches to understanding the relationships between genotype, signaling, and therapeutic efficacy$770,101
U01 · FY2020 · CA
Mouse models of Kras-mutant colorectal cancer$646,021
R01 · FY2020 · CA · contact PI
Tissue-specific genetic interactions in cancer$499,355
R01 · FY2020 · CA · contact PI
Systems approaches to understanding the relationships between genotype, signaling, and therapeutic efficacy$823,431
U01 · FY2019 · CA
Tissue-specific genetic interactions in cancer$507,221
R01 · FY2019 · CA · contact PI
A multi-faceted approach to identifying K-Ras synthetic lethal relationships$349,929
U01 · FY2019 · CA · contact PI
A multi-faceted approach to identifying K-Ras synthetic lethal relationships$150,000
U01 · FY2019 · CA · contact PI
A multi-faceted approach to identifying K-Ras synthetic lethal relationships$1,041,188
U01 · FY2018 · CA · contact PI
Systems approaches to understanding the relationships between genotype, signaling, and therapeutic efficacy$684,764
U01 · FY2018 · CA
Modeling KRAS genetic heterogeneity in mouse models$635,205
R01 · FY2018 · CA · contact PI
Tissue-specific genetic interactions in cancer$505,643
R01 · FY2018 · CA · contact PI
Basic and Translational studies of Ras-mutant colorectal cancer$359,556
R01 · FY2018 · CA · contact PI
A multi-faceted approach to identifying K-Ras synthetic lethal relationships$1,041,188
U01 · FY2017 · CA · contact PI
Systems approaches to understanding the relationships between genotype, signaling, and therapeutic efficacy$739,468
U01 · FY2017 · CA
Modeling KRAS genetic heterogeneity in mouse models$556,992
R01 · FY2017 · CA · contact PI
Basic and Translational studies of Ras-mutant colorectal cancer$359,556
R01 · FY2017 · CA · contact PI
A multi-faceted approach to identifying K-Ras synthetic lethal relationships$1,025,393
U01 · FY2016 · CA · contact PI
Modeling KRAS genetic heterogeneity in mouse models$535,118
R01 · FY2016 · CA · contact PI
Basic and Translational studies of Ras-mutant colorectal cancer$359,556
R01 · FY2016 · CA · contact PI
A multi-faceted approach to identifying K-Ras synthetic lethal relationships$1,080,326
U01 · FY2015 · CA · contact PI
Basic and Translational studies of Ras-mutant colorectal cancer$359,556
R01 · FY2015 · CA · contact PI
In vivo systems biology of neurodegenerative diseases$332,757
R01 · FY2015 · AG · contact PI
Basic and Translational studies of Ras-mutant colorectal cancer$378,056
R01 · FY2014 · CA · contact PI
Cell-of-origin effects on development of colon cancer$365,423
R01 · FY2014 · CA
In vivo systems biology of neurodegenerative diseases$264,468
R01 · FY2014 · AG · contact PI
In vivo systems biology of neurodegenerative diseases$78,582
R01 · FY2014 · AG · contact PI
Cell-of-origin effects on development of colon cancer$354,120
R01 · FY2013 · CA
In vivo systems biology of neurodegenerative diseases$324,182
R01 · FY2013 · AG · contact PI
In vivo systems biology of inflammatory response in the intestinal epithelium$407,091
R01 · FY2012 · GM · contact PI
Cell-of-origin effects on development of colon cancer$376,724
R01 · FY2012 · CA
In vivo systems biology of neurodegenerative diseases$343,903
R01 · FY2012 · AG · contact PI
In vivo systems biology of inflammatory response in the intestinal epithelium$407,091
R01 · FY2011 · GM · contact PI
Cell-of-origin effects on development of colon cancer$376,150
R01 · FY2011 · CA
In vivo systems biology of neurodegenerative diseases$361,113
R01 · FY2011 · AG · contact PI
In vivo systems biology of inflammatory response in the intestinal epithelium$411,203
R01 · FY2010 · GM · contact PI
Cell-of-origin effects on development of colon cancer$184,720
R01 · FY2010 · CA
Genetic and genomic analysis of Ras signaling in colorectal cancer progression$147,826
K01 · FY2010 · CA · contact PI
In vivo systems biology of inflammatory response in the intestinal epithelium$434,169
R01 · FY2009 · GM · contact PI
Genetic and genomic analysis of Ras signaling in colorectal cancer progression$162,964
K01 · FY2009 · CA · contact PI
Genetic and genomic analysis of Ras signaling in colorectal cancer progression$101,679
K01 · FY2009 · CA · contact PI
Genetic and genomic analysis of Ras signaling in colorectal cancer progression$162,964
K01 · FY2008 · CA · contact PI
Genetic and genomic analysis of Ras signaling in colorectal cancer progression$102,670
K01 · FY2006 · CA · contact PI
Genetic and genomic analysis of Ras signaling in colorectal cancer progression$102,670
K01 · FY2006 · CA · contact PI